Stories by Monya Baker

Curcumin dupes assays and leads some drug hunters astray

Bad chemical probes have messed up clinical trials for breast cancer

Concerns that stem cells  could cause cancer in recipients are fading further with a new study

Cell lines made by two separate teams could boost the prospects of patient-specific therapies

The finding results from a data-crunching effort that highlighted drugs affecting the activity of genes involved in organ rejection

Transplanted "liver buds" self-organized to grow into functional organs, staving off death in mice with liver failure

Multicountry analyses spotlight a dark problem

An eel popular in sushi has muscle fibers that could offer an opportunity for advances in bioimaging

The flexible needles could help doctors deliver stem cells to broader areas of the brain with fewer injections. Such therapies are being investigated for Parkinson's disease, stroke and other neurodegenerative disorders

Fears of an immune response to replacement tissues have been overestimated, new research suggests, rejecting previous findings about possible side effects

Human excreta could be a powerful source of cells to study disease, bypassing some of the problems of using stem cells, such as the risk of developing tumors and difficulties in obtaining blood samples from children

The studies could help revamp treatments for the world's most deadly cancer, making them more specific to the mutation patterns

The data storage project represents the largest piece of nonbiological data ever stored in this manner

Women's third-trimester microbiota resemble that of people at risk of diabetes

The thinking behind an approach that has caused trouble in California